In a filing, Perspective Therapeutics Inc revealed its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0 on Mar 28 ’25. In the deal valued at $2.24 per share,22,026 shares were bought. As a result of this transaction, Spoor Johan M. now holds 59,383 shares worth roughly $0.24 million.
Then, Spoor Johan M. bought 4,650 shares, generating $10,288 in total proceeds. Upon buying the shares at $2.21, the Chief Executive Officer now owns 4,650 shares.
Before that, Williamson Robert F III bought 38,145 shares. Perspective Therapeutics Inc shares valued at $81,775 were divested by the Director at a price of $2.14 per share. As a result of the transaction, Williamson Robert F III now holds 108,982 shares, worth roughly $0.44 million.
H.C. Wainwright initiated its Perspective Therapeutics Inc [CATX] rating to a Buy in a research note published on March 13, 2025; the price target was $10. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. BofA Securities also remained covering CATX and has decreased its forecast on November 25, 2024 with a “Neutral” recommendation from previously “Buy” rating. UBS started covering the stock on October 24, 2024. It rated CATX as “a Buy”.
Price Performance Review of CATX
On Friday, Perspective Therapeutics Inc [AMEX:CATX] saw its stock fall -2.17% to $4.06. Over the last five days, the stock has lost -3.33%. Perspective Therapeutics Inc shares have fallen nearly -68.65% since the year began. Nevertheless, the stocks have risen 27.27% over the past one year. While a 52-week high of $16.55 was reached on 07/21/25, a 52-week low of $1.60 was recorded on 04/09/25.
Levels Of Support And Resistance For CATX Stock
The 24-hour chart illustrates a support level at 3.90, which if violated will result in even more drops to 3.75. On the upside, there is a resistance level at 4.19. A further resistance level may holdings at 4.32.
How much short interest is there in Perspective Therapeutics Inc?
A steep rise in short interest was recorded in Perspective Therapeutics Inc stocks on 2025-07-15, growing by 0.73 million shares to a total of 6.35 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.62 million shares. There was a rise of 11.51%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 01, 2024 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
